Added 2 days ago Drug news

Phase III LEAP 1 trial of BC 3781 (lefamulin) meets primary endpoint in community-acquired bacterial pneumonia.- Nabriva Therapeutics.

Nabriva Therapeutics announced positive topline results from the BC 3781 (lefamulin) evaluation against pneumonia (LEAP 1) trial, which evaluated the...

Added 2 days ago Drug news

FDA approves Solosec (secnidazole) for treatment of bacterial vaginosis.- Symbiomix Therapeutics.

Symbiomix Therapeutics announced the FDA has approved Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in...

Added 14 days ago Drug news

Phase III CONVERT study showed that the addition of ALIS (amikacin liposome inhalation suspension) to guideline-based therapy eliminated evidence of nontuberculous mycobacterial lung disease caused by mycobacterium avium complex.- Ismed.

The global CONVERT study met its primary endpoint of culture conversion by Month 6 with statistical and clinical significance. The...

Guidelines on Urological Infections

Due to the increasing threat of resistant pathogens worldwide, it has become imperative to limit the use of antibiotics, and...

Added 1 year ago

Safety guideline: skin antisepsis for central neuraxial blockade

Concise guidelines are presented that recommend the method of choice for skin antisepsis before central neuraxial blockade. The Working Party...

Added 3 years ago

United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014

The main objective is to assist practitioners in managing men and women diagnosed with Trichomonas vaginalis. This guideline offers recommendations...

Added 3 years ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 4 months ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 4 months ago

Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors.

Skin and soft tissue infections are common reasons for medical care. Use of broad-spectrum therapy and costs have increased. Assessment of early treatment response has been given a central role both in clinical trials and everyday practice. 

Added 11 months ago